NASDAQ:SNWV Sanuwave Health Q3 2026 Earnings Date & Estimates $5.62 -0.22 (-3.77%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$5.62 0.00 (-0.09%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Sanuwave Health is scheduled to report Q3 2026 earnings on Friday, November 6, 2026. The conference call is scheduled for 8:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 6, 2026Conference Call8:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Sanuwave Health in Q3 2026Sanuwave Health is expected to post earnings of $0.01 per share on revenue of $13.75 million. In the same quarter a year earlier Sanuwave Health reported $0.46 per share on revenue of $11.45 million. Sanuwave Health last reported on August 6, 2026, posting -$0.08 per share and missing the -$0.03 consensus estimate. Sanuwave Health has beaten the consensus EPS estimate in 2 of its last 5 quarters.Consensus EstimatesConsensus EPS$0.01Expected Revenue$13.75 millionPrior-Year EPS$0.46Prior-Year Revenue$11.45 millionExpected EPS Growth-97.8%Expected Revenue Growth+20.1%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.08 (Missed by -$0.05)Last Quarter Revenue$9.74 millionEPS Beat Rate2 of last 5 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Sanuwave Health Q3 2026 Earnings FAQ When does Sanuwave Health report Q3 2026 earnings? Sanuwave Health (NASDAQ:SNWV) is scheduled to report Q3 2026 earnings on Friday, November 6, 2026. What time is Sanuwave Health's Q3 2026 earnings call? Sanuwave Health's Q3 2026 earnings conference call is scheduled for Friday, November 6, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Sanuwave Health? Analysts expect Sanuwave Health to post earnings of $0.01 per share for Q3 2026. How much revenue is Sanuwave Health expected to report? The consensus revenue estimate for Sanuwave Health is $13.75 million for Q3 2026. Sanuwave Health Earnings HeadlinesCarlsmed (NASDAQ:CARL) versus Sanuwave Health (NASDAQ:SNWV) Financial ReviewOctober 8 at 4:45 AM | americanbankingnews.comFinancial Contrast: Alphatec (NASDAQ:ATEC) vs. Sanuwave Health (NASDAQ:SNWV)October 8 at 2:15 AM | americanbankingnews.comAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly 80% afterward. He also called the housing crisis and the collapse of Bear Stearns and Lehman Brothers before they happened. Now Tilson says the day after this year's midterm elections, America enters a period of economic change unlike anything seen in decades - and most investors are unprepared. | Stansberry Research (Ad)Sanuwave Health (NASDAQ:SNWV) Stock Price Up 4.3% - What's Next?October 3, 2026 | americanbankingnews.comEden Prairie medical device maker receives Nasdaq delisting noticeSeptember 28, 2026 | bizjournals.comSANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from S&P Global BMI IndexSeptember 21, 2026 | marketscreener.comMSee More Sanuwave Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sanuwave Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sanuwave Health and other key companies, straight to your email. Email Address About Sanuwave HealthSanuwave Health (NASDAQ:SNWV), Inc. is a medical technology company focused on regenerative medicine and the development of noninvasive treatments for wound healing and tissue repair. Its technology uses acoustic shock waves to stimulate biological responses that may support blood-vessel growth, tissue regeneration and healing. The company’s principal product is the dermaPACE System, an extracorporeal shock wave therapy device designed for use in treating chronic wounds, including diabetic foot ulcers. SANUWAVE has also pursued applications of its technology in other wound-care and tissue-repair areas, such as pressure ulcers, venous ulcers, burns and certain musculoskeletal conditions. SANUWAVE has historically sought to commercialize its products in the United States and international markets, including regions where applicable regulatory clearances and distribution arrangements are available. The company’s activities have centered on clinical development, regulatory approvals and commercialization of its regenerative medicine platform.View Sanuwave Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
